Font Size: a A A
Keyword [Receptor tyrosine]
Result: 161 - 180 | Page: 9 of 10
161. The Role Of Local Ablation Thepray For Advanced EGFR-mutant NSCLC Patients With Oligometastatic Disease Or Oligoprogressive Disease
162. The Effect And Molecular Mechanism Of Multikinase Inhibitor PKC412 In Colorectal Cancer Cells
163. Proteomics In Non-Small Cell Lung Cancer Patients For Prediction Of Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors And Chemotherapy
164. Study Of Anti-ovarian Cancer Effects And Mechanisms Induced By Ovarian Cancer Stem Cell Vaccines
165. Function And Mechanism Of Receptor Tyrosine Kinase TIE In Vascular Development And Maintenance
166. The Role Of Rerum VEGF In Determining EGFR-TKI Acquired Resistance In Lung Adenocarcinoma
167. Serum Albumin And CEA Are Associated With Prognosis Of EGFR-TKI Treatment In Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation
168. The Effect Of Non-receptor Tyrosine Kinase BMX On LPS-stimulated Macrophage In Secretion Of Pro-inflammatory Cytokine TNF-? And Phagocytosis Of E.coli
169. Effects Of Non-receptor Tyrosine Kinase Abelson On Autophagy Inhibited By 1-methyl-4-phenylpyridinium Ion In Mouse SN4741 Cells
170. Studies On The Interaction Between Mutant Soluble Ectodomain Of Human Fibroblast Growth Factor Receptor 2?c(ms FGFR2c) And EGFR
171. Correlation Between PD-L1 Expression And EGFR Mutation In Lung Adenocarcinoma
172. Modulation Of ALDHA1 Activity Reverses Stem-like Cell-mediated EGFR-TKI Resistance In NSCLC
173. MiR-625-3p Modulates Gefitinib Resistance Through AXL In Non-small Cell Lung Cancer
174. Clinical Characteristics And Molecular Mechanism Of Transformation From Adenocarcinoma To Small-cell Lung Cancer In EGFR Mutant Patients After EGFR-TKI
175. Efficacy Of Chemotherapy And Oral Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor In Lung Adenocarcinoma
176. The Prognosis Of Transmembrane Receptor Tyrosine Kinase AXL And C-MET In Gastrointestinal Tumors
177. Clinical Study Of "Qing Xuan Fei Re Fa" On The Efficacy Of Skin Rash After Applying EGFR-TKI In Patients With Lung Cancer
178. The Role Of Leptin Receptor Tyrosine 985 Phosphorylation Site In The Regulation Of Emotional Behavior
179. Analysis Of Clinical Effect And Gene Monitoring Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor In The Treatment Of Advanced Non-small Cell Lung Cancer
180. The Latest Progress Of Targeted Therapy Non-samll Cell Lung Cancer With Brain Metastases
  <<First  <Prev  Next>  Last>>  Jump to